PAA Post AGM ,, 2022 Highlights, page-4

I will do an easy one first.
MND was very light touch as there is a webinar next week (Tuesday) from the ladies running the trial.

My take outs
- We now have 5 in the trial (one more since last update which was not so long ago)
- we have 6 required for the first cohort (so at 5 out of 6 now)
- first cohort hoped to be fully recruited and though the 28 days by christmas (but data will likely take longer - note also it will be christmas)
- so far everything is going well and no adverse events
- second cohort of 6 will have a dose escalation
- then there will be a cohort 3 and 4 (6 in each)
- treatment for those on trial will be available to continue should they wish
- The board seems VERY up beat on MND (IMO)

I am really looking forward to the webinar.

I am working on a dogs post - there is a load to share. hope it won't be long, just doing some detail checking now.

adreamer

if i missed anything or you have a Q, throw it up on this and will try and answer.